Metagenomi Therapeutics, Inc.
MGX
$1.16
-$0.01-0.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -41.14% | -37.97% | -35.24% | -32.95% | -31.65% |
| Total Receivables | -60.40% | -61.72% | -47.32% | 3.24% | -25.43% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -34.22% | -26.38% | -52.41% | -37.54% | -4.23% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -41.20% | -38.01% | -35.83% | -32.76% | -31.18% |
|
|
|||||
| Total Current Assets | -41.20% | -38.01% | -35.83% | -32.76% | -31.18% |
| Net Property, Plant & Equipment | -20.47% | -18.61% | -17.82% | -16.70% | -15.59% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -10.61% | -11.76% | 8.93% | 8.78% | 8.48% |
| Total Assets | -36.21% | -33.88% | -31.88% | -30.81% | -29.44% |
|
|
|||||
| Total Accounts Payable | -9.96% | -10.19% | 179.36% | -60.84% | -16.28% |
| Total Accrued Expenses | 28.79% | -23.24% | -19.53% | 14.20% | -41.45% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.20% | 8.96% | 7.74% | 18.63% | 2.08% |
| Total Finance Division Other Current Liabilities | -40.96% | -63.50% | -61.90% | -55.86% | -44.03% |
| Total Other Current Liabilities | -40.96% | -63.50% | -61.90% | -55.86% | -44.03% |
| Total Current Liabilities | -16.93% | -43.60% | -38.53% | -35.26% | -37.01% |
|
|
|||||
| Total Current Liabilities | -16.93% | -43.60% | -38.53% | -35.26% | -37.01% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -16.00% | -14.81% | -13.82% | -12.77% | -11.90% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -64.65% | -44.64% | -59.65% | -75.40% | -73.00% |
| Total Liabilities | -20.04% | -30.56% | -30.35% | -32.25% | -34.37% |
|
|
|||||
| Common Stock & APIC | 2.31% | 2.54% | 2.64% | 2.79% | 2.86% |
| Retained Earnings | -34.88% | -34.63% | -39.40% | -44.46% | -48.18% |
| Treasury Stock & Other | -132.80% | -107.09% | -63.33% | -77.36% | 240.38% |
| Total Common Equity | -42.52% | -35.21% | -32.47% | -30.23% | -27.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -42.52% | -35.21% | -32.47% | -30.23% | -27.31% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -42.52% | -35.21% | -32.47% | -30.23% | -27.31% |
|
|
|||||